
News Digest
CAC2 Childhood Cancer Community News Digest (April 27-May 3)
Assorted News from the Last Week: A pioneering trial from Cancer Grand Challenges team NexTGen will test CAR-T cell therapies designed from CAC2 Supporting Organization
Home » Research & Treatment Focus Area » Foundation Match
● Better coordination and reduced duplication
For more information contact the Research Interest Group at research@cac2.org.

Assorted News from the Last Week: A pioneering trial from Cancer Grand Challenges team NexTGen will test CAR-T cell therapies designed from CAC2 Supporting Organization

CAC2 recently hosted a webinar, Understanding Childhood Cancer Risk and Early Indicators, on April 22, 2026. The session explored an important and evolving question in

Assorted News from the Last Week: CAC2 Supporting Organization Day One Biopharmaceuticals announced that Ibsen was awarded conditional marketing authorization for tovorafenib for children with